AAAAAA
Results: 26-50/696
Authors:
BOREEN D
JUGE D
STAHL J
TORBORG S
Citation: D. Boreen et al., EFFECTS OF A PHYSICIAN EDUCATION-PROGRAM ON PRESCRIBING OF HMG-COA REDUCTASE INHIBITORS, Formulary (Cleveland, Ohio), 33(8), 1998, pp. 802
Citation: STEPS FOR DEVELOPING AND IMPLEMENTING A DVT TREATMENT PROTOCOL IN THEOUTPATIENT SETTING, Formulary (Cleveland, Ohio), 33(8), 1998, pp. 819-820
Citation: SIGNIFICANT OTOTOXICITY SEEN WITH ONCE-DAILY GENTAMICIN DOSING IN STEM-CELL TRANSPLANT RECIPIENTS - FROM THE UNIVERSITY-OF-TEXAS MD-ANDERSON-CANCER-CENTER, HOUSTON, Formulary (Cleveland, Ohio), 33(8), 1998, pp. 820-820
Authors:
WECHSLER J
Citation: J. Wechsler, CONGRESS CONSIDERS NEW FDA COMMISSIONER AND NEED TO OVERHAUL RESEARCHPROTECTIONS, Formulary (Cleveland, Ohio), 33(8), 1998, pp. 822
Citation: AGGRASTAT - PLATELET INHIBITOR FOR USE WITH HEPARIN IN ACUTE CORONARYSYNDROME, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 610
Citation: INTEGRILIN - PLATELET INHIBITOR FOR TREATING ACUTE CORONARY SYNDROME,ANGIOPLASTY, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 619-620
Citation: ALREX, LOTEMAX - TOPICAL CORTICOSTEROID SOLUTIONS FOR REDUCING OPHTHALMIC INFLAMMATION, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 619-619
Citation: SIMULECT - IMMUNOSUPPRESSIVE TO PREVENT ACUTE REJECTION IN RENAL-TRANSPLANT PATIENTS, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 620-621
Citation: XELODA - ORAL-AGENT FOR METASTATIC BREAST-CANCER RESISTANT TO STANDARD CHEMOTHERAPY, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 621-621
Citation: NEUPOGEN - TO IMPROVE NEUTROPHIL RECOVERY, REDUCE FEVER DURATION AFTER CHEMOTHERAPY FOR AML, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 621-621
Citation: SURVEY FINDS HMOS, PBMS STILL MOVING TO RESTRICTED FORMULARIES, QUICKLY ADVANCING IN INFORMATICS, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 622
Citation: INAPPROPRIATE DOSING, OTHER SHORTCOMINGS WIDESPREAD IN SCHIZOPHRENIA DRUG-THERAPY, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 625-626
Citation: SINGLE-ISOMER VERSION OF ALBUTEROL PROMISES MORE POTENT BRONCHODILATION, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 626
Citation: EXPERT PANEL ISSUES DRUG GUIDELINES FOR AGITATION IN ELDERLY DEMENTIAPATIENTS, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 629-630
Citation: FLUVASTATIN SHOWN FOR FIRST TIME TO REDUCE CARDIAC EVENTS IN PATIENTSWITH SYMPTOMATIC CHD, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 630-630
Authors:
DUNN A
CHOW MSS
Citation: A. Dunn et Mss. Chow, FOCUS ON EPTIFIBATIDE - GP IIB IIIA INHIBITOR REDUCES COMPLICATIONS OF ANGIOPLASTY, ACUTE CORONARY SYNDROME/, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 632
Authors:
GOFF DA
Citation: Da. Goff, DETERMINING THE COST OF ANTIMICROBIAL THERAPY - A FOCUS ON FLUOROQUINOLONES, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 648
Authors:
CUNHA BA
Citation: Ba. Cunha, PART 2 OF 2 - FACTORS IN THE DEVELOPMENT AND MAINTENANCE OF A RATIONAL ANTIBIOTIC FORMULARY, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 659-662
Authors:
JOHNSON N
Citation: N. Johnson, NEW APPROACHES TO THE DEVELOPMENT AND USE OF TREATMENT GUIDELINES, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 665
Citation: SURGICAL PROPHYLAXIS PROTOCOL IMPROVES QUALITY OF CARE, DECREASES ANTIBIOTIC COSTS, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 697-697
Citation: CLASS REVIEW OF STATINS RESULTS IN FORMULARY CHANGES, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 697-698
Citation: COST CONSEQUENCES FROM SWITCHING FROM ONE DILTIAZEM FORMULATION TO ANOTHER, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 698-698
Authors:
WECHSLER J
Citation: J. Wechsler, NEW POLICIES PROMISE TO SPUR PEDIATRIC DRUG DEVELOPMENT, DOSING INFORMATION, Formulary (Cleveland, Ohio), 33(7), 1998, pp. 700
Citation: ACTONEL - BISPHOSPHONATE FOR TREATING PAGETS-DISEASE OF THE BONE, Formulary, 33(6), 1998, pp. 495-496
Citation: REFLUDAN - ANTICOAGULANT TO PREVENT COMPLICATIONS OF HEPARIN-INDUCED THROMBOCYTOPENIA, Formulary, 33(6), 1998, pp. 496